Affinity Asset Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Affinity Asset Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$25.1K	Buy
2024 Q4	–	Hold
2024 Q3	–	Hold
2022 Q3	–	Sell
2022 Q2	$721K	Buy